<DOC>
	<DOC>NCT01891786</DOC>
	<brief_summary>The primary objective of the CORDIA study is to use an effective evidence-based self-management intervention (SMI) for type 2 diabetes, with and without a novel test to give a personalised genetic and lifestyle risk of coronary heart disease, to examine their capacity to reduce the risk of coronary heart disease (CHD) and improve diabetes management in primary care patients with type 2 diabetes. The effect of these interventions on clinical, behavioural and psychological outcomes will be investigated.</brief_summary>
	<brief_title>Coronary Heart Disease Risk in Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Males and females aged 2570 years diagnosed with type 2 diabetes White, AfroCaribbean or AsianIndian ethnicity Most previous or baseline HbA1c â‰¥6.5% or 48 mmol/mol Fluency in written and spoken English Diagnosis of ischemic heart disease, stroke, Transient Ischaemic Attack (TIA) or peripheral vascular disease Serious or enduring mental health problems that would prevent the patient from completing the study Currently receiving treatment for a lifethreatening condition (e.g., cancer) or in the terminal stages of a condition Adults who cannot consent for themselves</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>